BIOTIDES

LIVE

Serial Number

79372781

Owner

JPT Peptide Technologies GmbH

Attorney

Monica Riva Talley

Filing Date

Jun 5, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BIOTIDES Trademark

Serial Number: 79372781 • Registration: 8237328

BIOTIDES is a trademark filed by JPT Peptide Technologies GmbH on June 5, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

JPT Peptide Technologies GmbH (9 trademarks)

Volmerstraße 5

Entity Type: 16

Legal Representation

Attorney of Record

Monica Riva Talley

2,921 trademarks filed View all →

Correspondence Address

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C

1101 K Street, N.W.

10th Floor

Washington, DC 20005

United States

Trademark Details

Filing Date

June 5, 2023

Registration Date

May 5, 2026

Published for Opposition

March 17, 2026

Goods & Services

Peptides for industrial purposes for use in the research and development of pharmaceuticals

Synthetic peptides for pharmaceutical purposes for the treatment and diagnosis of infectious diseases, pain, inflammation, cognitive disorders, cardiovascular, cardiopulmonary, oncological, respiratory, neurological, psychiatric, neurodegenerative diseases, and immune system related diseases and disorders and regenerative medicines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 5, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

May 5, 2026 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 17, 2026 NPUB

PUBLISHED FOR OPPOSITION

Mar 17, 2026 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 11, 2026 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 21, 2026 CNSA

EXAMINER'S AMENDMENT ENTERED

Feb 21, 2026 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 21, 2026 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 21, 2026 GNEA

EXAMINERS AMENDMENT -WRITTEN

Feb 21, 2026 CNEA

NOTIFICATION OF FINAL REFUSAL EMAILED

Feb 18, 2026 GNFN

FINAL REFUSAL E-MAILED

Feb 18, 2026 GNFR

FINAL REFUSAL WRITTEN

Feb 18, 2026 CNFR

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jan 29, 2026 ADCH

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Dec 30, 2025 RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Apr 15, 2025 RCCK

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 1, 2025 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Feb 1, 2025 OPNR

NEW REPRESENTATIVE AT IB RECEIVED

Jan 31, 2025 NREP

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Sep 28, 2024 GNS3

LETTER OF SUSPENSION E-MAILED

Sep 28, 2024 GNSL

SUSPENSION LETTER WRITTEN

Sep 28, 2024 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 27, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 27, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 27, 2024 TROA

REFUSAL PROCESSED BY IB

Apr 23, 2024 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Mar 29, 2024 RFCS

REFUSAL PROCESSED BY MPU

Mar 29, 2024 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 10, 2024 RFCR

NON-FINAL ACTION WRITTEN

Mar 9, 2024 CNRT

ASSIGNED TO EXAMINER

Feb 27, 2024 DOCK

APPLICATION FILING RECEIPT MAILED

Jul 7, 2023 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 3, 2023 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jun 29, 2023 REPR

Related Trademarks

More from this Owner

SPIKETIDES

PEPSTAR

PEPTRACK

More in Same Class

PPL PRIME PATHOLOGY LABORATORY PREVIEW

CMC